Algos Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
Algos Pharmaceuticals General Information
Description
Provider of undisclosed products and services based in the United States.
Contact Information
Corporate Office
- United States
Corporate Office
- United States
Algos Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Algos Pharmaceuticals Acquisitions (1)
Algos Pharmaceuticals’s most recent deal was a Reverse Merger with Endo International. The deal was made on 17-Jul-2000.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Endo International | 17-Jul-2000 | Reverse Merger | Pharmaceuticals |
Algos Pharmaceuticals Exits (1)
Algos Pharmaceuticals’s most recent exit was on 17-Jul-2000 from Endo International. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Endo International | 17-Jul-2000 | Completed |
|
Algos Pharmaceuticals FAQs
-
Where is Algos Pharmaceuticals headquartered?
Algos Pharmaceuticals is headquartered in .
-
What industry is Algos Pharmaceuticals in?
Algos Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Algos Pharmaceuticals a private or public company?
Algos Pharmaceuticals is a Private company.
-
What is Algos Pharmaceuticals’s current revenue?
The current revenue for Algos Pharmaceuticals is .
-
When was Algos Pharmaceuticals acquired?
Algos Pharmaceuticals was acquired on 17-Jul-2000.
-
Who acquired Algos Pharmaceuticals?
Algos Pharmaceuticals was acquired by Endo International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
